Laia Bonjoch

Sobre mí

Publicaciones destacadas

• Germline mutations in WNK2 could be associated with serrated polyposis syndrome

  Autores:

  Soares de Lima, Yasmin; Arnau-Collell, Coral; Munoz, Jenifer; Herrera-Pariente, Cristina; Moreira, Leticia;

  (...)

  Ruiz-Ponte, Clara; Valle, Laura; Balaguer, Francesc; Bonjoch, Laia; Castellvi-Bel, Sergi.

  Ver listado completo de autores

  Referencia: Journal Of Medical Genetics 2023.

• Unraveling the impact of a germline heterozygous <i>POLD1</i> frameshift variant in serrated polyposis syndrome

  Autores:

  Bonjoch, Laia; Soares de Lima, Yasmin; Diaz-Gay, Marcos; Dotti, Isabella; Munoz, Jenifer;

  (...)

  Pellise, Maria; Balaguer, Francesc; Salas, Azucena; Alexandrov, Ludmil B B; Castellvi-Bel, Sergi.

  Ver listado completo de autores

  Referencia: Frontiers In Molecular Biosciences 2023.

• Evaluating the Potential of Polygenic Risk Score to Improve Colorectal Cancer Screening

  Autores:

  Arnau-Collell, Coral; Diez-Villanueva, Anna; Bellosillo, Beatriz; Auge, Josep M; Munoz, Jenifer;

  (...)

  Grau, Jaume; Castells, Antoni; Borras, Josep M; Moreno, Victor; Castellvi-Bel, Sergi.

  Ver listado completo de autores

  Referencia: Cancer Epidemiology Biomarkers & Prevention 2022.

• Comprehensive Genomic Characterization of Fifteen Early-Onset Lynch-Like Syndrome Colorectal Cancers

  Autores:

  Golubicki, Mariano; Diaz-Gay, Marcos; Bonjoch, Laia; Franch-Exposito, Sebastia; Munoz, Jenifer;

  (...)

  Roca, Enrique; Castells, Antoni; Balaguer, Francesc; Castellvi-Bel, Sergi; Antelo, Marina.

  Ver listado completo de autores

  Referencia: Cancers 2021.

• Identification of New Genes Involved in Germline Predisposition to Early-Onset Gastric Cancer

  Autores:

  Herrera-Pariente, Cristina; Capo-Garcia, Roser; Diaz-Gay, Marcos; Carballal, Sabela; Munoz, Jenifer;

  (...)

  Castells, Antoni; Balaguer, Francesc; Bujanda, Luis; Castellvi-Bel, Sergi; Moreira, Leticia.

  Ver listado completo de autores

  Referencia: International Journal Of Molecular Sciences 2021.

• Germline biallelic MCM8 variants are associated with early-onset Lynch-like syndrome

  Autores:

  Golubicki, Mariano; Bonjoch, Laia; Acuna-Ochoa, Jose G; Diaz-Gay, Marcos; Munoz, Jenifer;

  (...)

  Roca, Enrique; Castells, Antoni; Balaguer, Francesc; Antelo, Marina; Castellvi-Bel, Sergi.

  Ver listado completo de autores

  Referencia: Jci Insight 2020.

• Germline Mutations in FAF1 Are Associated With Hereditary Colorectal Cancer

  Autores:

  Bonjoch, Laia; Franch-Exposito, Sebastia; Garre, Pilar; Belhadj, Sami; Munoz, Jenifer;

  (...)

  Capella, Gabriel; Balaguer, Francesc; Caldes, Trinidad; Valle, Laura; Castellvi-Bel, Sergi.

  Ver listado completo de autores

  Referencia: Gastroenterology 2020.

• Approaches to functionally validate candidate genetic variants involved in colorectal cancer predisposition.

  Autores:

  Bonjoch, Laia; Mur, Pilar; Arnau-Collell, Coral; Vargas-Parra, Gardenia; Shamloo, Bahar;

  Franch-Exposito, Sebastia; Pineda, Marta; Capella, Gabriel; Erman, Batu; Castellvi-Bel, Sergi.

  Referencia: Molecular Aspects Of Medicine 2019.

• IL17 Functions through the Novel REG3 beta-JAK2-STAT3 Inflammatory Pathway to Promote the Transition from Chronic Pancreatitis to Pancreatic Cancer

  Autores:

  Loncle, Celine; Bonjoch, Laia; Folch-Puy, Emma; Lopez-Millan, Maria Belen; Lac, Sophie;

  (...)

  Dubus, Pierre; Lomberk, Gwen; Urrutia, Raul; Closa, Daniel; Iovanna, Juan L.;.

  Ver listado completo de autores

  Referencia: Cancer Research 2015.

Proyectos destacados

• Colorectal cancer in adolescents and young adults: identification of germline predisposition and somatic insults by a comprehensive multiomic characterization

  Investigador/a principal: Sergi Castellvi Bel

  Financiador: Fundacion Cientifica de la Asociacion Espanola contra el Cancer

  Código: AECC_Proyectos21

  Duración: 01/12/2021 - 30/11/2024

• Germline predisposition to colorectal cancer: functional characterization of new genes by CRISPR/CAS and organoid modeling (PARAGON)

  Investigador/a principal: Sergi Castellvi Bel

  Financiador: Instituto de Salud Carlos III

  Código: PI20/00113

  Duración: 01/01/2021 - 31/12/2023